Showing results (131-140 of 287) with videos related to
Sort By:
Pageof 29
Journal of Intellectual Disability Research : JIDR|December 17, 2008
The documentation of health problems in relation to prescribed medication in people with profound intellectual and multiple disabilitiesD C van der Heide, A A J van der Putten, P B van den Berg, et al.Studies in Health Technology and Informatics|September 16, 2010
Mapping stakeholders for system evaluation - the case of the Electronic Prescription Service in EnglandV Lichtner, D Petrakaki, R Hibberd, et al.Molecular and Cellular Biology|June 1, 1995
Mutants of the RNA-dependent protein kinase (PKR) lacking double-stranded RNA binding domain I can act as transdominant inhibitors and induce malignant transformationG N Barber, M Wambach, S Thompson, et al.Human Gene Therapy|December 17, 2011
Retargeting vesicular stomatitis virus using measles virus envelope glycoproteinsCamilo Ayala-Breton, Glen N Barber, Stephen J Russell, et al.Academic Pediatrics|June 12, 2021
Addressing Pediatric Mental Health Using Telehealth During Coronavirus Disease-2019 and Beyond: A Narrative ReviewNatoshia R Cunningham, Samantha L Ely, Brittany N Barber Garcia, et al.Cancer Cell|May 1, 2018
Extrinsic Phagocyte-Dependent STING Signaling Dictates the Immunogenicity of Dying CellsJeonghyun Ahn, Tianli Xia, Ailem Rabasa Capote, et al.Journal of Clinical Pharmacy and Therapeutics|December 13, 2005
Measuring the appropriateness of prescribing in primary care: are current measures complete?N Barber, C Bradley, C Barry, et al.Anaesthesia|December 1, 1992
Continuous extradural infusion of lignocaine 0.75% vs bupivacaine 0.125% in primiparae: quality of analgesia and influence on labourR Milaszkiewicz, N Payne, B Loughnan, et al.Open Veterinary Journal|February 22, 2021
Long-term outcome following cranial biceps brachii tendon transposition in a dog with a traumatic cranial scapulohumeral luxationLauren N Barber, Daniel D Lewis, Erin G Porter, et al.Clinical and Experimental Pharmacology & Physiology|July 20, 2000
Type-C natriuretic peptide prevents development of experimental atherosclerosis in rabbitsT A Gaspari, M N Barber, R L Woods, et al.Pageof 29